The Oncology Institute rebrands as Starling Oncology; ticker changes to STLN

Oncology Institute, Inc.

Company name changed to Starling Oncology, Inc. effective July 28, 2026.
Common stock ticker symbol changes from TOI to STLN effective August 4, 2026.
No stockholder approval required; CUSIP number remains 68236X100.
CEO Dan Virnich says rebrand reflects scale and coordinated care model.
Patient care unaffected; same phone numbers and portal access maintained.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.